PON1 Antibody (OTI2D4) [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-73526H
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Paraffin
Label
HRP
Antibody Source
Monoclonal Mouse IgG2B Clone # OTI2D4
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for PON1 Antibody (OTI2D4) [HRP]
Immunogen
Full length recombinant protein of human PON1 (NP_000437) produced in HEK293T cells.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for PON1 Antibody (OTI2D4) [HRP]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PON1
Long Name
Paraoxonase 1
Alternate Names
ESA, K-45
Gene Symbol
PON1
Additional PON1 Products
Product Documents for PON1 Antibody (OTI2D4) [HRP]
Product Specific Notices for PON1 Antibody (OTI2D4) [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...